Journal of Rheumatic Diseases

Cited by CrossRef (25)

  1. Jung Hee Koh, Yusun Lee, Hyoun-Ah Kim, Jinhyun Kim, Kichul Shin. Comparison of remission criteria in patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying anti-rheumatic drugs: results from a nationwide registry. Therapeutic Advances in Musculoskeletal 2022;14
    https://doi.org/10.1177/1759720X221096363
  2. Seulkee Lee, Seonyoung Kang, Hyungjin Kim, Jaejoon Lee, Min-Ji Kim, Hoon-Suk Cha. Sex-specific disparities in disease activity scores among patients with axial spondyloarthritis and their implications for evaluating the response to tumor necrosis factor alpha inhibitor therapy. Arthritis Res Ther 2024;26
    https://doi.org/10.1186/s13075-024-03320-x
  3. Oh Chan Kwon, Min-Chan Park. Drug Retention Rate and Factors Associated with Discontinuation of Interleukin-17 Inhibitors in Patients with Axial Spondyloarthritis. Yonsei Med J 2023;64:697
    https://doi.org/10.3349/ymj.2023.0151
  4. Young Ho Lee, Gwan Gyu Song. Association between the functional FCGR3AF158V and FCGR2AR131H polymorphisms and responsiveness to biologics in rheumatoid arthritis patients: A meta‐analysis. Int J of Rheum Dis 2023;26:1295
    https://doi.org/10.1111/1756-185X.14719
  5. Jung Gon Kim, Bon San Koo, Joo-Hyun Lee, Bo Young Yoon. Anemia as an indicator of a higher retention rate for tocilizumab versus tumor necrosis factor inhibitors in patients with rheumatoid arthritis from a Korean multicenter registry. J Rheum Dis 2024;31:212
    https://doi.org/10.4078/jrd.2024.0026
  6. Young Ho Lee, Gwan Gyu Song. Associations between the interleukin-6 rs1800795 G/C and interleukin-6 receptor rs12083537 A/G polymorphisms and response to disease-modifying antirheumatic drugs in rheumatoid arthritis: A meta-analysis. International Immunopharmacology 2022;112:109184
    https://doi.org/10.1016/j.intimp.2022.109184
  7. Young Ho Lee, Gwan Gyu Song. Relative effectiveness and safety of interleukin-6 and Janus kinase inhibitors versus adalimumab in patients with rheumatoid arthritis: a network meta-analysis. Z Rheumatol 2023;82:696
    https://doi.org/10.1007/s00393-022-01290-6
  8. Ji-Won Kim, Eunyoung A. Lee, Hyoun-Ah Kim, Chang-Hee Suh, Ju-Yang Jung. Clinical Features and Drug Retention of TNF Inhibitors in Older Patients with Ankylosing Spondylitis: Results from the KOBIO Registry. BioDrugs 2022;36:411
    https://doi.org/10.1007/s40259-022-00524-y
  9. Sun-Kyung Lee, Kichul Shin, Ju-Yang Jung, Chang-Hee Suh, Ji-Won Kim, Hyoun-Ah Kim. Retention Rate and Safety of Biologic and Targeted Synthetic DMARDs in Patients with RA-Associated Interstitial Lung Disease: A KOBIO Registry Study. BioDrugs 2023
    https://doi.org/10.1007/s40259-023-00578-6
  10. Ayu Paramaiswari, Deddy Nur Wachid Achadiono, Nyoman Kertia, Dhite Bayu Nugroho, Min Jung Kim, Kichul Shin. Establishing the Indonesian Systemic Lupus Erythematosus Regional (ISLET) Registry: Aftermath of the Asia Pacific League of Associations for Rheumatology (APLAR) Center of Excellence Exchange Program. Int J of Rheum Dis 2024;27
    https://doi.org/10.1111/1756-185X.70020
  11. Jun Won Park, Ju Yeon Kim, Min Jung Kim, Yoo Kyoung Lim, Hyoun-Ah Kim, Jin Hyun Kim, Kichul Shin. Impact of concomitant methotrexate on disease activity in patients with rheumatoid arthritis tapering abatacept: results from KOBIO registry. Front. Med. 2024;11
    https://doi.org/10.3389/fmed.2024.1418243
  12. Min Jung Kim, Sun-Kyung Lee, Sohee Oh, Hyoun-Ah Kim, Yong-Beom Park, Shin-Seok Lee, Kichul Shin. Efficacy of Abatacept Versus Tumor Necrosis Factor Inhibitors in Anti-citrullinated Protein Antibody-Positive Patients with Rheumatoid Arthritis: Results from a Korean Nationwide Biologics Registry. Rheumatol Ther 2022;9:1143
    https://doi.org/10.1007/s40744-022-00467-4
  13. Young Ho Lee. Comparative Efficacy and Safety of Janus Kinase Inhibitors and Secukinumab in Patients with Active Ankylosing Spondylitis: A Systematic Review and Meta-Analysis. Pharmacology 2022;107:537
    https://doi.org/10.1159/000525627
  14. Seong-Ryul Kwon, Tae-Hwan Kim, Tae-Jong Kim, Won Park, Seung Cheol Shim. The Epidemiology and Treatment of Ankylosing Spondylitis in Korea. J Rheum Dis 2022;29:193
    https://doi.org/10.4078/jrd.22.0023
  15. Hong Ki Min, Se Hee Kim, Sang-Heon Lee, Hae-Rim Kim. Risk factors for interstitial lung disease in rheumatoid arthritis: a cohort study from the KOBIO registry. Therapeutic Advances in Musculoskeletal 2024;16
    https://doi.org/10.1177/1759720X231218098
  16. Bora Nam. Optimization of biological therapy selection in rheumatoid arthritis: insights into anemia and interleukin-6 pathway. J Rheum Dis 2025;32:1
    https://doi.org/10.4078/jrd.2024.0133
  17. Young Ho Lee, Gwan Gyu Song. Relative efficacy and safety of Janus kinase inhibitors for the treatment of active psoriatic arthritis: a network meta-analysis. Z Rheumatol 2023;82:408
    https://doi.org/10.1007/s00393-021-01119-8
  18. Hyoun-Ah Kim, So Young Park, Kichul Shin. Implications of Persistent Pain in Patients With Rheumatoid Arthritis Despite Remission Status: Data From the KOBIO Registry. J Rheum Dis 2022;29:215
    https://doi.org/10.4078/jrd.22.0005
  19. Dong-Jin Park, Hyemin Jeong, Sung-Eun Choi, Ji-Hyoun Kang, Shin-Seok Lee. Impact of obesity on clinical outcomes and treatment continuation in rheumatoid arthritis patients receiving non-TNF-targeted therapies. Therapeutic Advances in Musculoskeletal 2024;16
    https://doi.org/10.1177/1759720X241308027
  20. Jisoo Lee, Yoon-Kyoung Sung, Myeung-Su Lee, Han Joo Baek. The Korean College of Rheumatology: 40 Years of Public Health Influence. J Rheum Dis 2022;29:75
    https://doi.org/10.4078/jrd.2022.29.2.75
  21. Soo Min Ahn, Young Bin Joo, Yun Jin Kim, So-Young Bang, Hye-Soon Lee. Pregnancy Outcomes Associated With Biologic Agent Exposure in Patients With Several Rheumatic Diseases and Inflammatory Bowel Diseases. J Korean Med Sci 2023;38
    https://doi.org/10.3346/jkms.2023.38.e172
  22. Jinhyun Kim, Min Jung Kim, Geun Young Oh, Sun Kyung Lee, Taeeun Kim, Kichul Shin. The predictability of ASDAS on drug survival in patients with ankylosing spondylitis on biologic therapy: data from the KOBIO registry. Therapeutic Advances in Musculoskeletal 2023;15
    https://doi.org/10.1177/1759720X231201714
  23. Hyoun-Ah Kim, Eunyoung Lee, So Young Park, Shin-Seok Lee, Kichul Shin. Clinical Characteristics of Patients With Psoriatic Spondylitis Versus Those With Ankylosing Spondylitis: Features at Baseline Before Biologic Therapy. J Korean Med Sci 2022;37
    https://doi.org/10.3346/jkms.2022.37.e253
  24. M. Kwon, C. I. Joung, H. Shin, C. C. Lee, Y. S. Song, Y. J. Lee, S. Kang, J. Y. Kim, S. Lee. Detection of novel drug-adverse drug reaction signals in rheumatoid arthritis and ankylosing spondylitis: analysis of Korean real-world biologics registry data. Sci Rep 2024;14
    https://doi.org/10.1038/s41598-024-52822-w
  25. Ju-Yang Jung, Eunyoung Lee, Ji-Won Kim, Chang-Hee Suh, Kichul Shin, Jinhyun Kim, Hyoun-Ah Kim. Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry. Arthritis Res Ther 2023;25
    https://doi.org/10.1186/s13075-023-03165-w